ADHD

May 24, 2023

Child Health Poll: more than 1-in-4 Tennessee parents worried their kids have undiagnosed depression, anxiety

The latest analysis of the 2023 Tennessee Child Health Poll, released during National Mental Health Awareness Month, has found that roughly 29% of Tennessee parents are concerned their child has undiagnosed anxiety or depression.

By Jake Lowary
April 2, 2021

Study links ADHD pharmacotherapy and retention rates for substance use disorder treatment

Kristopher Kast, MD, assistant professor in the Department of Psychiatry and Behavioral Sciences and clinical director of Vanderbilt’s Addiction Consult Service, has discovered a strong association between attention-deficit/hyperactivity disorder (ADHD) pharmacotherapy and retention rates for substance use disorder (SUD) treatment.

By Emily Stembridge
July 16, 2020

Nearly one-third of Tennessee parents are worried their child has an undiagnosed mental health condition, new poll finds

One-third of Tennessee parents with children ages 6-17 are worried their child has an undiagnosed mental health condition, a new poll from the Vanderbilt Center for Child Health Policy found.

By Jake Lowary
July 24, 2019

Defective transporter linked to autism

A first-of-its-kind mouse model may help reveal mechanistic underpinnings for the altered behaviors of autism spectrum disorder.

By Bill Snyder
October 23, 2014

‘Darting’ mice may hold clues to ADHD, autism and bipolar disorder

The transgenic mouse, into which was inserted a rare human genetic variation in the dopamine transporter, could lead to improvements in the diagnosis and treatment of these all-too-common brain disorders.

By Bill Snyder
February 27, 2014

U.S. Senate hearing explores ADHD treatment concerns

William Cooper, M.D., MPH, Cornelius Vanderbilt Professor of Pediatrics and Health Policy, testified Tuesday before the U.S. Senate Health, Education, Labor and Pensions (HELP) committee regarding psychotropic medications and treatments for Attention Deficit Hyperactivity Disorder (ADHD).

By Christina Echegaray
November 7, 2013

Neurotransmitter’s role in bone balance

Removal of the neurotransmitter norepinephrine from the space outside cells plays an important role in the regulation of bone remodeling.
By Leigh MacMillan
September 19, 2013

Transporter linked to autism risk

Vanderbilt University investigators for the first time have linked a non-inherited, de novo mutation in the dopamine transporter to autism spectrum disorder (ASD).
By Bill Snyder
August 22, 2013

Antipsychotic drug use in children for mood/behavior disorders increases type 2 diabetes risk

Prescribing “atypical” antipsychotic medications to children and young adults with behavioral problems or mood disorders may put them at unnecessary risk for type 2 diabetes, a Vanderbilt University Medical Center study shows.
By VUMC News and Communications
May 15, 2012

New clue to ADHD

A rare genetic change adds support to the idea that altered dopamine signaling is a key risk factor for ADHD.
By Bill Snyder
April 6, 2012

Minds wide open: Neuroscience at Vanderbilt

Vanderbilt University has emerged as one of the nation’s leading academic centers in neuroscience.
By Bill Snyder
November 2, 2011

Vanderbilt study finds no heart risk in ADHD medications

Attention Deficit Hyperactivity Disorder (ADHD) medications do not increase the risk for heart disease or heart attack in children and young adults, according to a Vanderbilt study of 1.2 million patients taking drugs including Ritalin, Adderall, Concerta and Strattera between 1998 and 2005.
By VUMC News and Communications